organism: Homo sapiens
identifiers.namespace: BioSample
identifiers.id: SAMN31276454
identifiers.namespace: pda|hayywjp@orcid
identifiers.id: E100023610
attributes.tag: isolate
attributes.value: Lower left lobe of lung
attributes.tag: age
attributes.value: 65 years old
attributes.tag: biomaterial_provider
attributes.value: Huaian First Peoples Hospital, Nanjing Medical University
attributes.tag: sex
attributes.value: male
attributes.tag: tissue
attributes.value: lung cancer tissues
attributes.tag: disease
attributes.value: synchronous multiple primary lung cancer
attributes.tag: disease_stage
attributes.value: IIIa (pT2bN2M0)
attributes.tag: ethnicity
attributes.value: Han Chinese
attributes.tag: sample_type
attributes.value: Tissue sample
attributes.tag: treatment
attributes.value: Patient received surgery and administration of the second generation ALK inhibitor named Ensartinib hydrochloride with a dose of 225 mg per day.
attributes.tag: BioSampleModel
attributes.value: Human